HomeOCEA • NASDAQ
add
Ocean Biomedical Inc
Previous close
$0.044
Day range
$0.042 - $0.048
Year range
$0.039 - $2.44
Market cap
7.91M USD
Avg Volume
50.91M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.75M | 365.61% |
Net income | 283.00K | 101.68% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | 902.00K | -83.60% |
Total liabilities | 98.52M | 2.34% |
Total equity | -97.62M | — |
Shares outstanding | 166.01M | — |
Price to book | -0.02 | — |
Return on assets | -430.92% | — |
Return on capital | 5.65% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 283.00K | 101.68% |
Cash from operations | -2.52M | -190.99% |
Cash from investing | — | — |
Cash from financing | 2.50M | 198.45% |
Net change in cash | -16.00K | 40.74% |
Free cash flow | -4.49M | -247.31% |
About
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Founded
2019
Headquarters
Website
Employees
7
